Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Capital Leases (2025 - 2026)

Updated

Vivos Therapeutics (VVOS) reported Capital Leases of $83,000 for Q2 2026, down 41.1% from $141,000 a year earlier and down 15.3% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Capital Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, Vivos Therapeutics posted Capital Leases of $113,000.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $98,000 (Q1 2026), $113,000 (Q4 2025) and $125,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83,000.00
Mar 31, 2026 98,000.00
Dec 31, 2025 113,000.00
Sep 30, 2025 125,000.00
Jun 30, 2025 141,000.00
API Access

Vivos Therapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=VVOS&period=max&api_key=YOUR_API_KEY